Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

Arysta agreement

8 Feb 2010 07:00

RNS Number : 7903G
Plant Impact PLC
08 February 2010
 



 

8 February 2010

 

Plant Impact plc

 

("Plant Impact" or the "Company")

 

 

Plant Impact and Arysta LifeScience Sign Evaluation, Development and Distribution Agreement for Crop Nutrient Products

 

 

Plant Impact plc (AIM:PIM), a global developer of technologies that improve crop productivity, is pleased to announce that on 5 February 2010 it entered into an exclusive evaluation, development and distribution agreement (the "agreement") with Arysta LifeScience Corporation covering the Company's InCa, Balance and Cocoa Stress Tolerance products (the "Crop Nutrient Products").

 

This is a significant milestone for Plant Impact as the agreement will:

·; extend territorial coverage of the Crop Nutrient Products from 24 countries to 52 countries.

·; increase field trial development of the Crop Nutrient Products. Arysta LifeScience is planning approximately 350 field trials over the next 12 to 18 months which means that, including the Company's currently planned field trial programme, this will result in more than 500 field trials being conducted.

·; increase the commercial potential of the Crop Nutrient Products.

 

The agreement covers countries in North America (excluding InCa), Central and Latin America, Europe, Africa and the Far East. Initial crop targets are in high value horticulture with potential extension into some arable crops.

 

Pursuant to the agreement, Arysta LifeScience will have exclusivity to evaluate the Crop Nutrient Products until 31 March 2011. The evaluation of the Crop Nutrient Products represents the field trial development stage referred to above and will be carried out to research standard. Once this is complete Arysta LifeScience will ensure products are registered locally, and will market and distribute these products on an exclusive basis. Detailed development and distribution agreements will be signed country by country as they come on stream.

 

"Plant nutrients are an important and growing component of our product portfolio", said Wayne Hewett, president and CEO of Arysta LifeScience. "The combination of Plant Impact's innovation platform and our global market development and distribution capabilities make an exciting partnership. We are delighted to further strengthen our relationship with Plant Impact".

 

Pete Blezard, CEO of Plant Impact commented, "This is a tremendous achievement for all stakeholders involved. Agriculture is challenged to feed the world during a time when the population is increasing and natural resources are decreasing. We firmly believe that new science and technologies that are sustainable, environmentally safe, which increase crop marketable yield and yet are able to decrease wastage and conserve natural resources are the way forward. Plant Impact has such science and technologies. With this agreement our company has significantly expanded its route to market and continues to prove efficacy and commercial viability."

 

 

For further information, please contact:

Plant Impact Plc

Peter Blezard, Chief Executive Officer

+44 (0) 1772 645 164

Nominated Adviser and Joint Broker

Allenby Capital

Nick Naylor / Jamie Boyd

 

+44 (0) 20 3328 5661

Joint Broker

Hybridan LLP

Stephen Austin / Claire Noyce

+44 (0) 207 947 4004

 

Financial PR/IR

Conduit PR

Charlie Geller

+44 (0) 20 7429 6604

 

 

Notes to Editors

 

About Arysta LifeScience Corporation

Headquartered in Tokyo, Japan, Arysta LifeScience is the world's largest privately held crop protection and life science company with 2008 revenues of US$1.3 billion. An entrepreneurial provider of crop protection and life science products in more than 125 countries worldwide. More than three-quarters of the Arysta LifeScience organisation is directly involved in bringing products to market, from more than 1,200 sales and marketing representatives working with growers, to development and registration teams, to supply chain specialists.

 

More information on Arysta LifeScience is available at: www.arystalifescience.com.

 

About Plant Impact plc

 

Plant Impact addresses the increasing global demand for effective, sustainable and ecologically-sound products to combat environmental plant stress and improve crop productivity. Common environmental plant stresses include drought, salinity, nutrient deficiencies, pests and disease. Plant Impact's advances produce practical results that reduce inputs and benefit the whole of the agricultural value chain, providing solutions for growers, food manufacturers and consumers.

 

A broad product portfolio has been developed using these innovative and proprietary technologies, the most advanced of which are already being marketed and sold through established agricultural distribution networks. Products for the home and garden market are also distributed direct to consumers through reputable high street stores.

 

About InCa

 

InCa is a product derived from Plant Impact's CaT technology. This technology is a calcium absorption aid. In trials it has been found to deliver calcium to the plant up to 50 times more effectively than traditional calcium products and with fewer applications and less input.

 

CaT alleviates the problems encountered by growing crops under environmental stress (drought, heat, cold) and physiological diseases in the ongoing development of the fruit that are often due to calcium deficiencies. This technology enables calcium uptake and retention in the tissues of the plant that would not naturally absorb calcium under normal growing conditions.

 

About Balance

Balance is a product derived from Plant Impact's Speedo technology. Speedo technology has the ability to increase the efficacy of nutrient products. It accelerates reproductive growth leading to faster and better colour, flowering, sugar production and maturity. Earlier yielding crops give the option for additional harvest and or prolonged harvests of extra crops. Speedo technology can be incorporated into other Plant Impact products such as the PiNT technology range as well as into other manufacturers fertilisers under license.

About Cocoa Stress Tolerance ("CST")

CST is a product based principally on Plant Impact's Alethea stress relief technology in combination with PiNT technology. It enables cocoa plants to withstand disease attack by increasing nutrient levels and plant health. There are no cures for diseases such as Frosty Pod and Black Pod so cocoa growers are dependent upon fungicides to reduce yield loss. CST therefore presents growers with the opportunity to reduce fungicide use while adding to the health of the plant nutritionally.

In a 3 year trial on the Costa Rican cocoa crop CST was found to increase cocoa yield by 67% by simply improving disease resistance. In addition calcium levels were also increased by 25% which has a beneficial effect on the flavour of cocoa products such as chocolate.

 

 

For further information please visit www.plantimpact.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKKPDNOBKDQBK
Date   Source Headline
6th Jan 20162:05 pmRNSDirector's Dealing
30th Nov 20155:08 pmRNSNotification of Major Interest in Shares
25th Nov 20153:09 pmRNSResult of AGM
25th Nov 20157:00 amRNSTrading update
2nd Nov 20152:52 pmRNSAnnual Report and AGM Notice
2nd Nov 20157:00 amRNSPresentation at World Agri-Tech Investment Summit
26th Oct 20157:00 amRNSPreliminary Results
28th Sep 20157:00 amRNSSignificant R&D Appointments
4th Sep 20157:00 amRNSTrading Update
31st Jul 201511:48 amRNSChief Executive Officer's Restricted Share Units
9th Jul 20154:48 pmRNSHolding(s) in Company
3rd Jul 20154:37 pmRNSInvestor Open Day
3rd Jul 20158:00 amRNSDirectors Dealing and Total Voting Rights
3rd Jul 20157:00 amRNSLaunch of Cocoa Yield Enhancement Product
2nd Jul 20154:48 pmRNSBlock Listing Application
3rd Jun 20157:00 amRNSTrading Update
1st Jun 20151:34 pmRNSKey Senior Management Appointments
27th May 20159:38 amRNSHolding(s) in Company
30th Apr 20157:01 amRNSBoard Changes
20th Apr 20152:44 pmRNSHolding(s) in Company
1st Apr 20157:00 amRNSDirector's Dealing
26th Mar 20157:00 amRNSInterim Results
6th Mar 201510:03 amRNSHolding(s) in Company
5th Mar 20152:29 pmRNSHolding(s) in Company
5th Mar 20152:24 pmRNSHolding(s) in Company
2nd Mar 20152:26 pmRNSHolding(s) in Company
27th Feb 20157:00 amRNSProposed Placing
16th Feb 20157:00 amRNSSignificant additional Bayer CropScience agreement
9th Feb 20157:00 amRNSTrading Update
1st Dec 20141:56 pmRNSIssue of Equity
20th Nov 20149:53 amRNSResults of AGM
20th Nov 20147:00 amRNSQ1 Trading Update
29th Oct 20142:00 pmRNSAnnual Report & Accounts and Notice of AGM
27th Oct 20147:00 amRNSFinal Results
15th Oct 20143:48 pmRNSHolding(s) in Company
11th Sep 20147:00 amRNSTrading Update
3rd Sep 20142:00 pmRNSCommercial Agreement
14th Jul 20148:20 amRNSHolding(s) in Company
5th Jun 20147:00 amRNSTrading Update
7th May 20149:14 amRNSHolding(s) in Company
28th Apr 20147:00 amRNSInterim Results
4th Mar 20147:00 amRNSTrading Update
14th Feb 20147:00 amRNSAppointment of Peel Hunt as Nomad and Broker
27th Jan 20148:04 amRNSDirector/PDMR Shareholding
16th Jan 201410:48 amRNSResult of AGM
17th Dec 20137:00 amRNSKey Management Appointments
13th Dec 20137:00 amRNSNotice of AGM
21st Nov 20133:01 pmRNSTrading Statement
21st Nov 20132:59 pmRNSFinal Results
21st Nov 20139:39 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.